Fatpipe Inc: Form 10-Q for the period ended Dec 31, 2025
Filed with the SEC on Feb 2, 2026 and accepted by EDGAR at Feb 2, 2026, 16:00 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-10-01 to 2025-12-31 | $4.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2025-04-01 to 2025-12-31 | $12.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-10-01 to 2025-12-31 | $503.8k | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2025-04-01 to 2025-12-31 | $1.0m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2025-10-01 to 2025-12-31 | $3.6m | us-gaap:GrossProfit |
| Gross profit | 9 months2025-04-01 to 2025-12-31 | $10.9m | us-gaap:GrossProfit |
| Research and development | 3 months2025-10-01 to 2025-12-31 | $453.5k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2025-04-01 to 2025-12-31 | $1.4m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2025-10-01 to 2025-12-31 | $402.4k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2025-04-01 to 2025-12-31 | $1.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2025-10-01 to 2025-12-31 | $104.1k | us-gaap:InterestExpense |
| Interest expense | 9 months2025-04-01 to 2025-12-31 | $300.0k | us-gaap:InterestExpense |
| Income tax | 3 months2025-10-01 to 2025-12-31 | $90.2k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2025-04-01 to 2025-12-31 | $292.8k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-10-01 to 2025-12-31 | $310.7k | us-gaap:ProfitLoss |
| Net income | 9 months2025-04-01 to 2025-12-31 | $1.0m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2025-10-01 to 2025-12-31 | $0.02 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-04-01 to 2025-12-31 | $0.07 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-10-01 to 2025-12-31 | $0.02 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-04-01 to 2025-12-31 | $0.07 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-10-01 to 2025-12-31 | 13,924,468 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-04-01 to 2025-12-31 | 13,855,297 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-04-01 to 2025-12-31 | $132.1k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2025-12-31 | $6.2m | us-gaap:Cash |
| Current assets | At period end2025-12-31 | $16.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $32.4m | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $6.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-12-31 | $11.2m | us-gaap:Liabilities |
| Long-term debt | At period end2025-12-31 | $4.6m | us-gaap:LongTermDebt |
| Current portion of debt | At period end2025-12-31 | $417.3k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2025-12-31 | $21.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001493152-26-004738. Last ingested by Listed: Oct 27, 2026, 16:07 ET. Listed shows no prices and gives no investment advice.